CERO THERAPEUTICS HOLDINGS, INC. Convertible Preferred Stock, Shares Issued upon Conversion
CERO THERAPEUTICS HOLDINGS, INC. (CERO) had Convertible Preferred Stock, Shares Issued upon Conversion of 625 shares as of 2025-09-30, per its 10-Q filed 2025-11-19.
Financial Statements › Notes › Equity › Stockholders' Equity Note › Class of Stock Disclosures › Features of Convertible Preferred Stock
us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion · last filed 2025-11-19
- 2025-09-30: Convertible Preferred Stock, Shares Issued upon Conversion 625.00 shares.
- 2025-03-31: Convertible Preferred Stock, Shares Issued upon Conversion 625.00 shares.
- 2024-12-31: Convertible Preferred Stock, Shares Issued upon Conversion 111.08K shares.
- 2023-12-31: Convertible Preferred Stock, Shares Issued upon Conversion 29.77M shares.
| Period end | Convertible Preferred Stock, Shares Issued upon Conversion |
|---|---|
| 2025-09-30 | 625.00 shares 10-Q · filed 2025-11-19 |
| 2025-03-31 | 625.00 shares 10-Q · filed 2025-08-22 |
| 2024-12-31 | 111.08K shares 10-K · filed 2025-04-15 |
| 2023-12-31 | 29.77M shares 10-Q · filed 2024-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |